Allergens in Popular Hair Products May Cause Allergic Contact ...
Aug 8, 2023 · Certain allergens in hair care products may cause allergic contact dermatitis (ACD) in some patients, resulting in eczematous lesions and swelling in the rinse-off distribution at …
Genetic Drivers Identified in Cherry Angioma
Feb 4, 2019 · A study recently published in JAMA Dermatology has identified 5 genetic factors contributing to cherry angiomas, supporting the role of genetics in its pathogenesis. Hot spot …
Lichen Amyloidosis (Lichen Amyloidosus, Papular Amyloidosis, …
Mar 13, 2019 · Are You Confident of the Diagnosis? Characteristic findings on physical examination Lichen amyloidosis is often described as a chronic, pruritic eruption of multiple …
Green Nail Syndrome (GNS, Pseudomonas nail infection, …
Mar 13, 2019 · Are You Confident of the Diagnosis? What you should be alert for in the history Green nail syndrome is caused by infection with Pseudomonas aeruginosa.
Hot tub folliculitis (Pseudomonas Folliculitis, Hot tub rash ...
Mar 13, 2019 · Are You Confident of the Diagnosis? Characteristic findings on physical examination Patients will typically present with follicular-based papules and pustules of the …
Underlying Etiologies of Cutaneous Flushing - Dermatology Advisor
Dec 14, 2017 · Cutaneous flushing, although common and often benign, may signal a more serious underlying pathology when the presentation extends beyond episodic warmth and …
Sebaceoma (Sebaceous epithelioma) - Dermatology Advisor
Mar 13, 2019 · Are You Confident of the Diagnosis? What you should be alert for in the history The term sebaceoma was introduced in 1984 by Troy and Ackerman to describe a benign …
Topical for Seborrheic Keratoses May Be Effective Alternative to ...
Sep 7, 2021 · Seborrheic keratosis treatment cream containing urea and hydroxy acids proved efficacious and safe.
Punctate Keratoderma & Myrmecia - Dermatology Advisor
May 2, 2024 · Examine two cases of differentiating cutaneous dells and explore their diagnoses of punctate keratoderma and myrmecia.
FDA Approves Nemluvio for Moderate to Severe Atopic Dermatitis
Dec 23, 2024 · The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.